{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:53:58Z","timestamp":1760820838226,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T00:00:00Z","timestamp":1477872000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s12328-016-0698-8","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T04:22:11Z","timestamp":1477887731000},"page":"47-51","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Complete response to post-transplant lymphoproliferative disorder by surgical resection and rituximab after living-donor liver re-transplantation for recurrent primary sclerosing cholangitis"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1686-3228","authenticated-orcid":false,"given":"Koichiro","family":"Haruki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Shiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimitsu","family":"Okui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Yanaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,31]]},"reference":[{"key":"698_CR1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","volume":"4","author":"G Opelz","year":"2004","unstructured":"Opelz G, D\u00f6hler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transpl. 2004;4:222\u201330.","journal-title":"Am J Transpl"},{"key":"698_CR2","first-page":"67","volume":"87","author":"G Muti","year":"2002","unstructured":"Muti G, Cantoni S, Oreste P, Cooperative Study Group on PTLDs, et al. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment. Haematologica. 2002;87:67\u201377.","journal-title":"Haematologica"},{"key":"698_CR3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000658-200210000-00005","volume":"236","author":"A Jain","year":"2002","unstructured":"Jain A, Nalesnik M, Reyes J, et al. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg. 2002;236:429\u201337.","journal-title":"Ann Surg"},{"key":"698_CR4","volume-title":"Post-transplant lymphoproliferative disorders. WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Webber SA, Chadburn A. Post-transplant lymphoproliferative disorders. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008."},{"key":"698_CR5","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1200\/JCO.2005.01.0934","volume":"23","author":"IM Ghobrial","year":"2005","unstructured":"Ghobrial IM, Habermann TM, Maurer MJ, et al. Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders. J Clin Oncol. 2005;23:7574\u201382.","journal-title":"J Clin Oncol"},{"key":"698_CR6","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1111\/ctr.12152","volume":"27","author":"M Mendizabal","year":"2013","unstructured":"Mendizabal M, Marciano S, dos Santos Schraiber L, et al. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience. Clin Transpl. 2013;27:E469\u201377.","journal-title":"Clin Transpl"},{"key":"698_CR7","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-6143.2010.03387.x","volume":"11","author":"R Reshef","year":"2011","unstructured":"Reshef R, Vardhanabhuti S, Luskin MR, et al. Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder. Am J Transpl. 2011;11:336\u201347.","journal-title":"Am J Transpl"},{"key":"698_CR8","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood-2005-01-0377","volume":"107","author":"S Choquet","year":"2006","unstructured":"Choquet S, Leblond V, Herbrecht R, et al. Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood. 2006;107:3053\u20137.","journal-title":"Blood"},{"key":"698_CR9","first-page":"417","volume":"94","author":"RJ Cruz Jr","year":"2012","unstructured":"Cruz RJ Jr, Ramachandra S, Sasatomi E, et al. Surgical management of gastrointestinal posttransplant lymphoproliferative disorders in liver transplant recipients. Transplantation. 2012;94:417\u201323.","journal-title":"Transplantation"},{"key":"698_CR10","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/01.tp.0000265914.16491.7d","volume":"83","author":"JM Smith","year":"2007","unstructured":"Smith JM, Corey L, Healey PJ, et al. Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients. Transplantation. 2007;83:1423\u20138.","journal-title":"Transplantation"},{"key":"698_CR11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1440-1797.2006.00596.x","volume":"11","author":"WH Lim","year":"2006","unstructured":"Lim WH, Russ GR, Coates PT. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Nephrology (Carlton). 2006;11:355\u201366.","journal-title":"Nephrology (Carlton)"},{"key":"698_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2015.08.007","volume":"369","author":"MR Petrara","year":"2015","unstructured":"Petrara MR, Giunco S, Serraino D, et al. Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment. Cancer Lett. 2015;369:37\u201344.","journal-title":"Cancer Lett"},{"key":"698_CR13","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117:5019\u201332.","journal-title":"Blood"},{"key":"698_CR14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1023\/A:1011131700811","volume":"12","author":"R Hauke","year":"2001","unstructured":"Hauke R, Smir B, Greiner T, et al. Clinical and pathological features of posttransplant lymphoproliferative disorders: influence on survival and response to treatment. Ann Oncol. 2001;12:831\u20134.","journal-title":"Ann Oncol"},{"key":"698_CR15","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1182\/blood-2009-07-143545","volume":"114","author":"HE Heslop","year":"2009","unstructured":"Heslop HE. How I treat EBV lymphoproliferation. Blood. 2009;114:4002\u20138.","journal-title":"Blood"},{"key":"698_CR16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","volume":"29","author":"IW Graziadei","year":"1999","unstructured":"Graziadei IW, Wiesner RH, Batts KP, et al. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology. 1999;29:1050\u20136.","journal-title":"Hepatology"},{"key":"698_CR17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","volume":"14","author":"J Alexander","year":"2008","unstructured":"Alexander J, Lord JD, Yeh MM, et al. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl. 2008;14:245\u201351.","journal-title":"Liver Transpl"},{"key":"698_CR18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2010.03402.x","volume":"11","author":"H Egawa","year":"2011","unstructured":"Egawa H, Ueda Y, Ichida T, et al. Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry. Am J Transpl. 2011;11:518\u201327.","journal-title":"Am J Transpl"},{"key":"698_CR19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1532\/IJH97.07012","volume":"86","author":"E Ishii","year":"2007","unstructured":"Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86:58\u201365.","journal-title":"Int J Hematol"},{"key":"698_CR20","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00595-010-4512-9","volume":"41","author":"A Soyama","year":"2011","unstructured":"Soyama A, Eguchi S, Takatsuki M, et al. Hemophagocytic syndrome after liver transplantation: report of two cases. Surg Today. 2011;41:1524\u201330.","journal-title":"Surg Today"},{"key":"698_CR21","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1600-6143.2011.03841.x","volume":"12","author":"J Shindoh","year":"2012","unstructured":"Shindoh J, Sugawara Y, Akamatsu N, et al. Thrombotic microangiopathy after living-donor liver transplantation. Am J Transpl. 2012;12:728\u201336.","journal-title":"Am J Transpl"},{"key":"698_CR22","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3748\/wjg.v17.i14.1848","volume":"17","author":"T Hori","year":"2011","unstructured":"Hori T, Kaido T, Oike F, et al. Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan. World J Gastroenterol. 2011;17:1848\u201357.","journal-title":"World J Gastroenterol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-016-0698-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-016-0698-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-016-0698-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:25:39Z","timestamp":1498343139000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-016-0698-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,31]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1007\/s12328-016-0698-8","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2016,10,31]]}}}